Targeting LRRK2 mRNA stability in Parkinson's disease.

Fasiczka, Rachel; Hilfiker, Sabine

Fasiczka, Rachel; Hilfiker, Sabine.

Affiliation

Fasiczka R; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA; Department of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
Hilfiker S; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA; Department of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Electronic address: sabine.hilfiker@rutgers.edu.

Trends Neurosci ; 47(1): 1-3, 2024 01.

Article in En | MEDLINE | ID: mdl-37858439

Subject(s)

Parkinson Disease; Animals; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/metabolism; Parkinson Disease/genetics; Parkinson Disease/metabolism; Models, Animal; Mutation

Key words

AICAr; ATIC; AUF1; mRNA decay; neurodegeneration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Limits: Animals Language: En Journal: Trends Neurosci Year: 2024 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google